Linked Life Data

21178641

Source:http://linkedlifedata.com/resource/pubmed/id/21178641

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-6-24
pubmed:abstractText
The route of estrogen administration is an important determinant of the risk of the first venous thromboembolism (VTE) event in postmenopausal women using hormone therapy (HT). However, the impact of transdermal estrogens on VTE recurrence risk has not been investigated. The aim of our study was to assess the impact of HT by route of estrogen administration on the risk of recurrent VTE.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1530-0374
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
488-93
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
pubmed:affiliation
Hormones and Cardiovascular disease team, CEPH Centre for Research in Epidemiology and Population Health, U1018, Inserm, F94807, Villejuit, France. valerie.olie@inserm.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't